![Yi Hui Wu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yi Hui Wu
Directeur Général chez Hangzhou Puyang Investment Management Co., Ltd.
Fortune : 72 M $ au 31/05/2024
Profil
Yi Hui Wu currently works at Zhejiang Tiansong Medical Instrument Co., Ltd., as Independent Director from 2019, Hangzhou Puyang Investment Management Co., Ltd., as General Manager & Executive Director from 2016, and Medtide, Inc., as Non-Executive Director from 2024.
Mr. Wu also formerly worked at Zhejiang Jindao Technology Co., Ltd., as Director.
Mr. Wu received his graduate degree from Zhejiang University of Finance & Economics.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
30/09/2023 | 10 363 914 ( 1,94% ) | 61 M $ | 31/05/2024 | |
31/12/2023 | 3 654 327 ( 4,04% ) | 11 M $ | 31/05/2024 |
Postes actifs de Yi Hui Wu
Sociétés | Poste | Début |
---|---|---|
Hangzhou Puyang Investment Management Co., Ltd.
![]() Hangzhou Puyang Investment Management Co., Ltd. Investment ManagersFinance Hangzhou Puyang Investment Management Co., Ltd. provides investment management services. The company was founded on April 15, 2009 and is headquartered in Hangzhou, China. | Directeur Général | 13/10/2016 |
Zhejiang Tiansong Medical Instrument Co., Ltd.
![]() Zhejiang Tiansong Medical Instrument Co., Ltd. Medical SpecialtiesHealth Technology Zhejiang Tiansong Medical Instrument Co., Ltd. engages in the research and development, production, and sale of endoscopic minimally invasive medical devices. Its products include abdominal surgery, orthopedic surgery, microsurgery, and gynecological endoscope minimally invasive medical equipment. The company was founded by Tian Song Xu and Tang Zhu Xu on August 28, 1998 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | 16/09/2019 |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
![]() Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Directeur/Membre du Conseil | 01/01/2022 |
Anciens postes connus de Yi Hui Wu
Sociétés | Poste | Fin |
---|---|---|
ZHEJIANG JINDAO TECHNOLOGY CO., LTD. | Directeur/Membre du Conseil | - |
Formation de Yi Hui Wu
Zhejiang University of Finance & Economics | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
![]() | Health Technology |
ZHEJIANG JINDAO TECHNOLOGY CO., LTD. | Distribution Services |
Entreprise privées | 2 |
---|---|
Hangzhou Puyang Investment Management Co., Ltd.
![]() Hangzhou Puyang Investment Management Co., Ltd. Investment ManagersFinance Hangzhou Puyang Investment Management Co., Ltd. provides investment management services. The company was founded on April 15, 2009 and is headquartered in Hangzhou, China. | Finance |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
![]() Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Health Technology |